GlaxoSmithKline buys 10% of German vaccine maker
July 20, 2020 at 11:08 AM EDT
The companies plan to develop up to five infectious disease therapies, but a potential Covid-19 vaccine is not on the list.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.